In 2012 the European Cardiovascular Research Institute (ECRI) was founded as a European collaborative effort to perform Investigator Sponsored Studies in the field of cardiology.
MASTER DAPT
The purpose of this trial is to compare, within current guidelines and instructions for use, an abbreviated versus a prolonged DAPT duration after bioresorbable polymer coated Ultimaster sirolimus-eluting stent implantation in patients presenting high-bleeding risk features.
The European Cardiovascular Research Institute (ECRI) acts as sponsor for the MASTER DAPT trial. ECRI was supported by a scientific grant from Terumo.
The MASTER DAPT trial is registered at clinicaltrials.gov:
-